XML 51 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets (Tables)
9 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Components of goodwill by business segment

The changes in the Company’s goodwill by reportable segment for the nine months ended June 30, 2023 are as follows (in thousands):

    

    

    

Life Sciences

Life Sciences

Products

Services

Total

Balance - September 30, 2022

$

154,612

$

359,011

$

513,623

Acquisitions

 

229,260

 

 

229,260

Currency translation adjustments

50,655

85

50,740

Balance - June 30, 2023

$

434,527

$

359,096

$

793,623

 

Schedule of intangible assets

The components of the Company’s identifiable intangible assets as of June 30, 2023 and September 30, 2022 are as follows (in thousands):

June 30, 2023

September 30, 2022

Accumulated

Net Book

Accumulated

Net Book

    

Cost

    

Amortization

    

Value

    

Cost

    

Amortization

    

Value

Patents

$

8,996

$

8,928

$

68

$

1,225

$

1,106

$

119

Completed technology

 

252,424

 

84,206

 

168,218

 

99,525

 

37,991

 

61,534

Trademarks and trade names

 

8,909

 

3,173

 

5,736

 

400

 

41

 

359

Non-competition agreements

731

586

145

681

439

242

Customer relationships

 

321,155

 

183,943

 

137,212

 

246,949

 

130,802

 

116,147

Other intangibles

904

228

676

202

202

Total

$

593,119

$

281,064

$

312,055

$

348,982

$

170,581

$

178,401

 

Schedule of future amortization expense

Estimated future amortization expense for the intangible assets for the remainder of fiscal year 2023 the subsequent five fiscal years and thereafter is as follows (in thousands):

2023

$

11,366

2024

 

50,664

2025

 

49,292

2026

 

45,908

2027

37,706

2028

31,219

Thereafter

85,900

Total

$

312,055